Product NDC: | 65862-113 |
Proprietary Name: | Hydrochlorothiazide |
Non Proprietary Name: | Hydrochlorothiazide |
Active Ingredient(s): | 12.5 mg/1 & nbsp; Hydrochlorothiazide |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-113 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078164 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070919 |
Package NDC: | 65862-113-01 |
Package Description: | 100 CAPSULE in 1 BOTTLE (65862-113-01) |
NDC Code | 65862-113-01 |
Proprietary Name | Hydrochlorothiazide |
Package Description | 100 CAPSULE in 1 BOTTLE (65862-113-01) |
Product NDC | 65862-113 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydrochlorothiazide |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20070919 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | HYDROCHLOROTHIAZIDE |
Strength Number | 12.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |